Ametek (AME) › Analysis

Ametek (AME) stock analysis, November 3, 2026: Earnings beat lifts uptrend, but breakout math falls short

Published November 3, 2026 · AME chart, levels and live analysis

AMETEK Inc. reported record third-quarter results on November 3, 2026, with sales up 17% to $2.22 billion, and raised full-year guidance; the stock rose about 3% to $249.30. The weekly uptrend is intact and the balance of evidence for the next two to six weeks leans positive, with medium conviction. The limit is the math: a breakout above $250 offers only 1 to 1 against the 52-week high, well short of 3 to 1.

Why it matters

The quarter was clean on every line. According to PR Newswire, sales rose 17% to $2.22 billion, adjusted earnings were $2.21 a share (also up 17%), and adjusted operating income climbed 20% to $594.7 million. Operating margin widened to 26.8%, and operating cash flow rose 27% to $560.6 million. The SEC filing carries the same figures. Ahead of the report, Investing.com put expectations at $2.11 a share and $2.12 billion in revenue, so AME cleared both and lifted its full-year outlook.

The reaction was positive but measured: a 3.05% gain on the day. That fits a stock with a high bar. AME is up 21.2% this year against 10.5% for the S&P 500 (SPY), and it sat 1.7% below its October 6 closing peak of $253.72 coming in. A beat and a raised guide were largely what the price already expected. Volume is running 12.9% below its 20-day average with the session still open, so buyers have not yet shown conviction.

Over five days AME is up 1.1% while SPY is down 2.1%. Today's jump is larger than the whole five-day gain, so the stock was slightly negative before earnings and the report did the lifting. No sector ETF figure is available, so the move cannot be split cleanly between market, sector and stock. The news provided does not explain the market's decline. The Morningstar morning briefing describes futures as mixed on election day. It also notes that industrial distributor Wajax missed, with adjusted EPS of CAD 0.60 against CAD 0.78 expected, so industrial results are not uniformly strong and AME's beat stands out.

The live argument about AME is how much of its growth is earned and how much is bought. The Investing.com preview framed the $5 billion acquisition as a test of the growth strategy. The company says the quarter was driven by strong organic growth and recent acquisitions, without a split in the material provided. The constructive case comes from Morningstar, which describes a wide-moat portfolio of niche equipment seeing high demand as U.S. manufacturing output rises, and an acquisition model that improves margins of the businesses it buys. A 26.8% operating margin supports that. No dedicated debate coverage was available this time.

On valuation, 18 analysts rate the stock a consensus buy with a mean price target of $282.06, which puts the shares 11.6% below it. Targets run from $217 to $318, so the lowest sits below today's price. The spread says analysts agree on direction but not on how much of the good news is already in the stock.

What the evidence says

The long-term thesis is intact. Price is above both its 10-week and 40-week averages, the 50-day average ($243.66) is above the 200-day ($234.52), and AME has led the S&P 500 by 4.1% over 50 days and 2.8% over 200. The stock is in a late-stage uptrend that has paused: it is 3.6% below its 52-week high of $258.52 and has slipped 1.2% over the past month while the market fell 2.1%.

For the next two to six weeks, the balance of evidence leans positive, with medium conviction, 2 of 4 points. Two things support it: the daily trend runs with the weekly uptrend, and AME is outperforming the market. The other two points are missing. Volume does not confirm the move, and the reward-to-risk on a breakout is thin. RSI at 52.5 shows neither stretch nor exhaustion, so there is room to run but no momentum signal pushing it.

The strongest case against is that the good news has arrived and the stock has stalled beneath resistance. Price is just under $250, the high-volume test has not happened, and the 52-week high is only 3.6% away, which caps the nearby upside. The stock has also given back ground over the past month despite a strong year. That is why conviction is medium rather than high. It does not tip the balance, because the trend structure is intact, support is close, and the earnings result gives buyers a reason to defend it.

Levels that matter

The structure holds above $243.66, the 50-day average. A close below it would be the first crack. The trend ends below $241.32, a swing zone that marks the prior low in the weekly pattern. Below that, the next supports are the 200-day average at $234.52 and swing zones at $229.97 and $226.11.

The breakout level is a daily close above $250.00, a round number, on volume above its 20-day average. From there the first target is the 52-week high at $258.52, with a stop at $241.88, which is the 50-day average minus a quarter of the 14-day ATR. That gives a reward-to-risk of 1.0, well short of 3 to 1. The math would approach 3 to 1 only with a target out near $275, the next round-number resistance beyond the high. Until price shows it can reach there, the breakout is a modest-reward trade.

What would change the picture

A weekly close below $241.32 would change the picture, because it would break the swing zone that defines the uptrend and put the stock under the 50-day average. The non-price fact that would do it is evidence that growth is slowing, such as organic growth fading or the raised full-year guidance being walked back, which would suggest that the acquisitions are carrying the numbers rather than the businesses.

What to watch

Get a message when the AME picture changes — the agent team watches the levels and the news for you.Create a free account

More AME analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.